|
Match
|
Document |
Document Title |
|
|
US20120128759 |
METHOD TO INHIBIT AIRWAY HYPERRESPONSIVENESS USING AEROSOLIZED T CELL RECEPTOR ANTIBODIES
Disclosed is a method to reduce airway hyperresponsivesness in an animal by the direct delivery to the lungs of aerosolized antibodies against T cell receptors. The method is particularly useful...
|
|
|
8178098 |
Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies
Disclosed is a method to reduce airway hyperresponsivesness in an animal by the direct delivery to the lungs of aerosolized antibodies against T cell receptors. The method is particularly useful...
|
|
|
US20120114663 |
METHODS TO TREAT ALLERGIC CONDITIONS
Disclosed are methods to treat allergic conditions, including pulmonary and non-pulmonary conditions, in a subject by administering a composition that inhibits Pim kinase. Also disclosed are...
|
|
|
8158107 |
Genes and proteins associated with angiogenesis and uses thereof
Disclosed is a panel of biomarkers associated with angiogenesis, and the use of such biomarkers (genes, proteins, homologues and analogs thereof) to regulate angiogenesis. Methods for identifying...
|
|
|
8143059 |
Method for identification of cell growth or differentiation factors
The present invention relates to novel immortalized precursor cell populations derived from embryonic stem cell populations and methods to produce such cell populations. Also disclosed is an assay...
|
|
|
US20120065611 |
DISPOSABLE VIAL HOLDER AND METHOD TO PREVENT NEEDLE STICK INJURIES
A vial holder is provided to protect a user's hand from needle sticks. The holder includes a handle and a shield attached to a distal end of the handle. An opening is formed in the distal end of...
|
|
|
8101361 |
Markers for diagnosis of pulmonary inflammation and methods related thereto
The present invention is related to the novel discovery of a number of genes that were identified as systemic markers of pulmonary inflammation. This discovery allows for development of a novel...
|
|
|
8058396 |
Cystatin C as an antagonist of TGF-β and methods related thereto
Disclosed are Cystatin C (CysC) homologues, including CystC homologues that act as antagonists or inhibitors of transforming growth factor-β (TGF-β). Also disclosed are methods to identify CystC h...
|
|
|
US20110250600 |
MARKER FOR CANCER PROGNOSIS AND METHODS RELATED THERETO
The present invention is related to the novel discovery that HIF-2α, but not HIF-1α, selectively regulates adenosine A2A receptor in endothelial cells, thereby revealing a unique and hitherto u...
|
|
|
US20110230974 |
AIRWAY ANCHOR SUTURE TO PREVENT AIRWAY STENT MIGRATION
An airway stent with an integral suture anchor is used to prevent migration of the stent within the airway. The suture anchor is incorporated by percutaneous placement of a suture through the neck...
|
|
|
US20110217315 |
METHODS AND COMPOSITIONS FOR RISK PREDICTION, DIAGNOSIS, PROGNOSIS, AND TREATMENT OF PULMONARY DISORDERS
The invention provides diagnostic and therapeutic targets for pulmonary disease, in particular, fibrotic lung disease. The inventors have found that a genetic variant MUC5B gene is associated with...
|
|
|
US20110212093 |
METHODS OF TREATING DISEASES WHICH ARE MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE CELLS
The present invention relates to methods of treating patients suffering from itching and puritis mediated by cutaneous lymphocyte antigen positive T cell. In particular, diseases or disorders...
|
|
|
7999082 |
Anti-factor B antibodies
Disclosed are novel inhibitors of the alternative complement pathway and particularly, novel anti-factor B antibodies. Also disclosed is the use of such inhibitors to reduce or prevent airway...
|
|
|
7994115 |
Three-dimensional structures of TALL-1 and its cognate receptors and modified proteins and methods related thereto
Disclosed are TALL-1 and TALL-1 receptor protein homologues (agonists and antagonists) designed based on the three-dimensional structure of sTALL-1, eBCMA and eBAFF-R; agonist homologues of APRIL;...
|
|
|
US20110136775 |
Methods for Treating Injury Associated with Exposure to an Alkylating Species
Compounds may be administered to prevent or rescue organ injury following exposure to alkylating agents, such as sulfur mustards. The compounds may be substituted metalloporphyrins.
|
|
|
US20110105452 |
Oxidant Scavengers for Treatment of Diabetes or Use in Transplantation or Induction of Immune Tolerance
The present invention relates, in one embodiment, to a method of preventing or treating diabetes using low molecular weight antioxidants. In a further embodiment, the invention relates to a method...
|
|
|
US20110097327 |
PRODUCT AND METHOD FOR TREATMENT OF CONDITIONS ASSOCIATED WITH RECEPTOR-DESENSITIZATION
Particular members of the multisubunit immune recognition receptor (MIRR) family of receptors, specifically, the B cell antigen receptor (BCR), the pre-B cell receptor (pre-BCR), the pro-B cell...
|
|
|
US20110003304 |
METHOD AND KIT FOR DETECTION OF AUTOIMMUNE CHRONIC URTICARIA
Disclosed is a rapid, non-invasive and highly specific and sensitive diagnostic assay for the identification of individuals with autoimmune chronic urticaria, which makes use of CD203c, and in some...
|
|
|
US20110002980 |
VACCINES USING NUCLEIC ACID-LIPID COMPLEXES
This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune...
|
|
|
US20100279351 |
Method for Generation of Antibodies
This invention generally relates to methods for the production of antibody producing cells and antibodies in protooncogene expressing animals. The invention also relates to methods for the...
|
|
|
7825224 |
Product and method for treatment of conditions associated with receptor-desensitization
Particular members of the multisubunit immune recognition receptor (MIRR) family of receptors, specifically, the B cell antigen receptor (BCR), the pre-B cell receptor (pre-BCR), the pro-B cell...
|
|
|
7825089 |
Three-dimensional structures of TALL-1 and its cognate receptors and modified proteins and methods related thereto
Disclosed are TALL-1 and TALL-1 receptor protein homologues (agonists and antagonists) designed based on the three-dimensional structure of sTALL-1, eBCMA and eBAFF-R; agonist homologues of APRIL;...
|
|
|
US20100272739 |
Modulation of Gamma-Delta T Cells to Regulate Airway Hyperresponsiveness
Disclosed is a method for regulation of airway hyperresponsiveness by modulating the action of γδ T cells in a patient. Also disclosed are methods for identifying compounds that regulate airway h...
|
|
|
US20100267644 |
Cystatin C as an Antagonist of TGF-BETA and Methods Related Thereto
Disclosed are Cystatin C (CysC) homologues, including CystC homologues that act as antagonists or inhibitors of transforming growth factor-β (TGF-β). Also disclosed are methods to identify CystC h...
|
|
|
US20100266600 |
METHODS OF USING IL-31 ANTAGONISTS IN DISEASES MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE T CELLS
The present invention relates to predicting therapeutic response of treating patients suffering from itching and puritis mediated by cutaneous lymphocyte antigen positive T cells in atopic...
|
|
|
7790762 |
Compounds and methods for thiol-containing compound efflux and cancer treatment
Methods for therapy of cystic fibrosis and other conditions such as cancer are provided. The methods comprise one or more agents capable of increasing thiol-containing compound transport via a...
|
|
|
US20100196376 |
METHOD FOR REDUCING ALLERGEN-INDUCED AIRWAY HYPERRESPONSIVENESS
Disclosed is a method to reduce airway hyperresponsiveness, such as allergen-induced airway hyperresponsiveness, in a mammal by administering an agent that increases the biological activity of a...
|
|
|
7754705 |
Cationic steroid antimicrobial compositions and methods of use
The invention provides methods for decreasing or inhibiting poxvirus infection or pathogenesis of a cell in vitro, ex vivo or in vivo, a symptom or pathology associated with poxvirus infection or...
|
|
|
7749958 |
Cystatin C as an antagonist of TGF-β and methods related thereto
Disclosed are Cystatin C (CysC) homologues, including CystC homologues that act as antagonists or inhibitors of transforming growth factor-β (TGF-β). Also disclosed are methods to identify CystC h...
|
|
|
7741300 |
Methods of using nucleic acid vector-lipid complexes
This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune...
|
|
|
7718618 |
Human cathelicidin antimicrobial peptides
Provided are peptide and peptide consensus sequences, which inhibit bacterial growth and/or viral growth and mimic the activity of LL-37, CRAMP, and/or FALL-39. The peptides are useful as...
|
|
|
US20090311231 |
PRODUCT AND PROCESS FOR LIQUEFACTION OF MUCUS OR SPUTUM
Disclosed are compositions and methods for decreasing the viscosity and/or cohesiveness of and/or increasing the liquefaction of excessively or abnormally viscous or cohesive mucus or sputum. The...
|
|
|
US20090254831 |
YAHRZEIT SYSTEM AND METHOD
A method of and system for providing an electronic Yahrzeit display corresponding to the current date including determining a current date, performing a search in a database storing a plurality of...
|
|
|
7582300 |
Modulation of gamma delta T cells to regulate airway hyperresponsiveness
Disclosed is a method for regulation of airway hyperresponsiveness by modulating the action of γδ T cells in a patient. Also disclosed are methods for identifying compounds that regulate airway h...
|
|
|
US20090162427 |
VACCINES USING NUCLEIC ACID-LIPID COMPLEXES
This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune...
|
|
|
7534438 |
Product and process for liquefaction of mucus or sputum
Disclosed are compositions and methods for decreasing the viscosity and/or cohesiveness of and/or increasing the liquefaction of excessively or abnormally viscous or cohesive mucus or sputum. The...
|
|
|
US20090093401 |
CYSTATIN C AS AN ANTAGONIST OF TGF-BETA AND METHODS RELATED THERETO
Disclosed are Cystatin C (CysC) homologues, including CystC homologues that act as antagonists or inhibitors of transforming growth factor-β (TGF-β). Also disclosed are methods to identify CystC h...
|
|
|
7498047 |
Methods for treatment of thiol-containing compound deficient conditions
Methods for therapy of cystic fibrosis and other conditions are provided. The methods comprise one or more agents capable of increasing thiol-containing compound transport via a transporter system...
|
|
|
7468048 |
Joint aspirate facilitating device
A joint aspirate-facilitating device is provided including a flexible main panel that is secured to the joint to be aspirated. An inflatable bladder is secured to the main panel and is placed in...
|
|
|
US20080306000 |
Three-Dimensional Structures of TALL-1 and its Cognate Receptors and Modified Proteins and Methods Related Thereto
Disclosed are TALL-1 and TALL-1 receptor protein homologues (agonists and antagonists) designed based on the three-dimensional structure of sTALL-1, eBCMA and eBAFF-R; agonist homologues of APRIL;...
|
|
|
US20080248025 |
Gamma Delta T Cells and Methods of Treatment of Interleukin-17 Related Conditions
This invention generally relates to methods to treat conditions and diseases associated with interleukin-17 (IL-17) production. The invention also relates to methods of inhibiting γδ T cells, and p...
|
|
|
US20080242640 |
Surfactant Lipids, Compositions Thereof and Uses Thereof
The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an...
|
|
|
US20080207556 |
Product and Process for Inhibition of Biofilm Development
Disclosed are compositions and methods for the inhibition of biofilm formation or reduction of existing or developing biofilms in a patient. These methods also inhibit the aggregation of bacteria...
|
|
|
US20080199509 |
Methods and Compositions for the Disruption of Biofilms
The invention relates to methods of inhibiting biofilm formation or reducing biofilms in a subject or on a device or surface by administering a charged compound such as a polyamino acid to a...
|
|
|
7374934 |
Cell populations and methods of production thereof
The present invention relates to novel immortalized precursor cell populations derived from embryonic stem cell populations and methods to produce such cell populations. Also disclosed is an assay...
|
|
|
US20080086070 |
Joint Aspirate Facilitating Device
A joint aspirate-facilitating device is provided including a flexible main panel that is secured to the joint to be aspirated. An inflatable bladder is secured to the main panel and is placed in...
|
|
|
US20080085883 |
OXIDANT SCAVENGERS FOR TREATMENT OF DIABETES OR USE IN TRANSPLANTATION OR INDUCTION OF IMMUNE TOLERANCE
The present invention relates, in one embodiment, to a method of preventing or treating diabetes using low molecular weight antioxidants. In a further embodiment, the invention relates to a method...
|
|
|
US20080070256 |
Non-Human Animal Models for B-cell Non-Hodgkin's Lymphoma and Uses Thereof
Disclosed are non-human animal models, and preferably, rodent models, and more preferably, mouse models, of B-cell Non-Hodgkin's Lymphoma (NHL). In particular, the present invention provides animal...
|
|
|
US20080064103 |
Product and method for treatment of conditions associated with receptor-desensitization
Particular members of the multisubunit immune recognition receptor (MIRR) family of receptors, specifically, the B cell antigen receptor (BCR), the pre-B cell receptor (pre-BCR), the pro-B cell...
|
|
|
US20080063629 |
METHOD FOR PRODUCTION OF NEUTROPHILS AND USES THEREFOR
An in vitro method for the differentiation of functionally mature neutrophils from stem cells is disclosed. Also disclosed are methods of producing genetically modified neutrophils in vitro and...
|